679 related articles for article (PubMed ID: 16829305)
1. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
[TBL] [Abstract][Full Text] [Related]
2. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
[TBL] [Abstract][Full Text] [Related]
3. HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses.
Dong Y; Denny TN
J Infect Dis; 2006 Jul; 194(2):168-75. PubMed ID: 16779722
[TBL] [Abstract][Full Text] [Related]
4. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
[TBL] [Abstract][Full Text] [Related]
5. Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox.
Ostrout ND; McHugh MM; Tisch DJ; Moormann AM; Brusic V; Kazura JW
Clin Exp Immunol; 2007 Aug; 149(2):265-73. PubMed ID: 17488297
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.
Terajima M; Cruz J; Raines G; Kilpatrick ED; Kennedy JS; Rothman AL; Ennis FA
J Exp Med; 2003 Apr; 197(7):927-32. PubMed ID: 12668642
[TBL] [Abstract][Full Text] [Related]
7. T-Cell epitope discovery for variola and vaccinia viruses.
Kennedy R; Poland GA
Rev Med Virol; 2007; 17(2):93-113. PubMed ID: 17195963
[TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
9. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.
Bolesta E; Gzyl J; Wierzbicki A; Kmieciak D; Kowalczyk A; Kaneko Y; Srinivasan A; Kozbor D
Virology; 2005 Feb; 332(2):467-79. PubMed ID: 15680412
[TBL] [Abstract][Full Text] [Related]
10. Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.
Didierlaurent A; Ramirez JC; Gherardi M; Zimmerli SC; Graf M; Orbea HA; Pantaleo G; Wagner R; Esteban M; Kraehenbuhl JP; Sirard JC
Vaccine; 2004 Sep; 22(25-26):3395-403. PubMed ID: 15308364
[TBL] [Abstract][Full Text] [Related]
11. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
[TBL] [Abstract][Full Text] [Related]
13. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
14. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
[TBL] [Abstract][Full Text] [Related]
15. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
16. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
[TBL] [Abstract][Full Text] [Related]
17. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.
Ennis FA; Cruz J; Demkowicz WE; Rothman AL; McClain DJ
J Infect Dis; 2002 Jun; 185(11):1657-9. PubMed ID: 12023773
[TBL] [Abstract][Full Text] [Related]
18. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
Jilek S; Schluep M; Harari A; Canales M; Lysandropoulos A; Zekeridou A; Pantaleo G; Du Pasquier RA
J Immunol; 2012 May; 188(9):4671-80. PubMed ID: 22461701
[TBL] [Abstract][Full Text] [Related]
19. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.
Terajima M; Orphin L; Leporati AM; Pazoles P; Cruz J; Rothman AL; Ennis FA
Hum Immunol; 2008 Dec; 69(12):815-25. PubMed ID: 18955096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
